American Medicines Company
Manufacturer of Generic Medication
Based in VA
AI Overview
With $510K in lobbying spend across 19 quarterly filings, American Medicines Company is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $30K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $120K |
| 2025 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that American Medicines Company disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Support for strengthening the domestic supply chain for generic medications
Support for strengthening the domestic supply chain for generic medications.
Appropriations/Fuding and Support for strengthening the domestic supply chain for generic medication manufacturing;
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.